-
Symbol
-
TCRX on Nasdaq
-
Investment type
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
1.35M shares
-
Security Ownership
-
2.52%
Adage Capital Management, L.P. ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)
2025-08-12 - Adage Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.35M shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX).
This represents 2.52% percent ownership of the company.